{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:24:53Z","timestamp":1795112693015,"version":"4.10.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Blood purification through the removal of plasma solutes by adsorption to beads of charcoal or resins contained in a cartridge (hemoperfusion) has a long and imperfect history. Developments in production and coating technology, however, have recently increased the biocompatibility of sorbents and have spurred renewed interest in hemoperfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a narrative assessment of the literature with focus on the technology, characteristics, and principles of hemoperfusion. We assessed publications in ex vivo, animal, and human studies. We synthesized such literature in a technical and state-of-the-art summary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Early hemoperfusion studies were hampered by bioincompatibility. Recent technology, however, has improved its safety. Hemoperfusion has been used with positive effects in chronic dialysis and chronic liver disease. It has also demonstrated extraction of a variety of toxins and drugs during episodes of overdose. Trials with endotoxin binding polymyxin B have shown mixed results in septic shock and are under active investigation. The role of non-selective hemoperfusion in sepsis or inflammation remains. Although new technologies have made sorbents more biocompatible, the research agenda in the field remains vast.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>New sorbents markedly differ from those used in the past because of greater biocompatibility and safety. Initial studies of novel sorbent-based hemoperfusion show some promise in specific chronic conditions and some acute states. Systematic studies of novel sorbent-based hemoperfusion are now both necessary and justified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-04009-w","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T12:10:52Z","timestamp":1652357452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":184,"title":["Hemoperfusion: technical aspects and state of the art"],"prefix":"10.1186","volume":"26","author":[{"given":"Claudio","family":"Ronco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"2","key":"4009_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000490694","volume":"48","author":"C Ronco","year":"2019","unstructured":"Ronco C, Ricci Z, Husain-Syed F. From multiple organ support therapy to extracorporeal organ support in critically ill patients. Blood Purif. 2019;48(2):99\u2013105.","journal-title":"Blood Purif"},{"issue":"1","key":"4009_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13054-018-2181-z","volume":"22","author":"G Ankawi","year":"2018","unstructured":"Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls. Crit Care. 2018;22(1):262.","journal-title":"Crit Care"},{"key":"4009_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000468911","volume":"190","author":"WR Clark","year":"2017","unstructured":"Clark WR, Ferrari F, La Manna G, Ronco C. Extracorporeal sorbent technologies: basic concepts and clinical application. Contrib Nephrol. 2017;190:43\u201357.","journal-title":"Contrib Nephrol"},{"key":"4009_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000060242","volume":"137","author":"C Ronco","year":"2002","unstructured":"Ronco C, Bordoni V, Levin NW. Adsorbents: from basic structure to clinical application. Contrib Nephrol. 2002;137:158\u201364.","journal-title":"Contrib Nephrol"},{"key":"4009_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/039139889802100604","volume":"21","author":"G La Greca","year":"1998","unstructured":"La Greca G, Brendolan A, Ghezzi PM, et al. The concept of sorbents in hemodialysis. Int J Artif Organs. 1998;21:303\u20138.","journal-title":"Int J Artif Organs"},{"issue":"4","key":"4009_CR6","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1046\/j.1523-1755.2003.00235.x","volume":"64","author":"T Abe","year":"2003","unstructured":"Abe T, Uchita K, Orita H, et al. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis. Kidney Int. 2003;64(4):1522\u20138.","journal-title":"Kidney Int"},{"key":"4009_CR7","unstructured":"Tetta C, Cavaillon JM, Camusi G, et al. Continuous plasma filtration coupled with sorbents. Kidney Int. 1998; 53(Suppl 66):S186\u2013S189.11."},{"key":"4009_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000046952","volume":"19","author":"C Ronco","year":"2001","unstructured":"Ronco C, Brendolan A, Winchester JF, et al. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove \u03b22-microglobulin in hemodialysis. Blood Purif. 2001;19:260\u20133.","journal-title":"Blood Purif"},{"key":"4009_CR9","doi-asserted-by":"crossref","unstructured":"Ferrari F, Clark WR, Ronco C: Sorbents: from basic structure to clinical application. In: Critical care Nephrology, Third Edition, Elsevier, 2019","DOI":"10.1016\/B978-0-323-44942-7.00189-8"},{"issue":"1","key":"4009_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000499076","volume":"48","author":"A Lorenzin","year":"2019","unstructured":"Lorenzin A, Neri M, de Cal M, Pajarin G, Mansi Montenegro G, Savastano S, Alghisi A, Ronco C. Fluid dynamics analysis by CT imaging technique of new sorbent cartridges for extracorporeal therapies. Blood Purif. 2019;48(1):18\u201324.","journal-title":"Blood Purif"},{"issue":"15","key":"4009_CR11","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.3390\/molecules25153331","volume":"25","author":"E Sarti","year":"2020","unstructured":"Sarti E, Chenet T, Stevanin C, Costa V, Cavazzini A, Catani M, Martucci A, Precisvalle N, Beltrami G, Pasti L. High-silica zeolites as sorbent media for adsorption and pre-concentration of pharmaceuticals in aqueous Solutions. Molecules. 2020;25(15):3331.","journal-title":"Molecules"},{"key":"4009_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/sdi.12246","volume":"27","author":"M Ghannoum","year":"2014","unstructured":"Ghannoum M, Bouchard J, Nolin TD, Ouellet G, Roberts DM. Hemoperfusion for the treatment of poisoning: technology, determinant of poison clearance, and application in clinical practice. Seminars Dial. 2014;27:350\u201361.","journal-title":"Seminars Dial"},{"key":"4009_CR13","doi-asserted-by":"crossref","unstructured":"Kawasaki CI, Nishi R, Uekihara. How tightly can a drug be bound to a protein and still be removal by charcoal hemoperfusion. In overdose cases. Clin Toxicol. 2005;43:95\u201399","DOI":"10.1081\/CLT-200050426"},{"key":"4009_CR14","doi-asserted-by":"crossref","unstructured":"Redant S, DeBels D, Ismaili K, Honore PM. Membrane-based therapeutic plasma exchange in intensive care. Blood Purif. 2021;5:290\u2013297.","DOI":"10.1159\/000510983"},{"key":"4009_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.ackd.2021.03.005","volume":"28","author":"AP Sanchez","year":"2021","unstructured":"Sanchez AP, Balogun RA. Therapeutic plasma exchange in the critically ill: technology and indications. Adv Chronic Kidney Dis. 2021;28:59\u201373.","journal-title":"Adv Chronic Kidney Dis"},{"key":"4009_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000510983","volume":"50","author":"S Redant","year":"2021","unstructured":"Redant S, De Bels D, Ismaili K, Honore P. Membrane-based therapeutic plasma exchange in intensive care. Blood Purif. 2021;50:290\u20137.","journal-title":"Blood Purif"},{"key":"4009_CR17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.4254\/wjh.v13.i8.904","volume":"13","author":"A Chris-Olaiya","year":"2021","unstructured":"Chris-Olaiya A, Kapoor A, Ricci KC, Lindenmeyer CC. Therapeutic plasma exchange in liver failure. Worl J Hepatol. 2021;13:904\u201311.","journal-title":"Worl J Hepatol"},{"key":"4009_CR18","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.3390\/ijms22168882","volume":"22","author":"K Moriyama","year":"2021","unstructured":"Moriyama K, Nishida O. Targeting cytokines, pathogen-associated molecular patterns and damage associated molecular patterns in sepsis via blood purification. Int J Mol Sci. 2021;22:8882.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4009_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/039139880202500105","volume":"25","author":"S Uchino","year":"2002","unstructured":"Uchino S, Bellomo R, Goldsmith D, et al. Cytokine removal with a large pore cellulose triacetate filter: an ex vivo study. Int J Artif Organs. 2002;25(1):27\u201332.","journal-title":"Int J Artif Organs"},{"issue":"11","key":"4009_CR20","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/ndt\/17.11.1950","volume":"17","author":"L Cole","year":"2002","unstructured":"Cole L, Bellomo R, Davenport P, et al. The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model. Nephrol Dial Transplant. 2002;17(11):1950\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"4009_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/039139880402700507","volume":"27","author":"L Cole","year":"2004","unstructured":"Cole L, Bellomo R, Davenport P, Tipping P, Ronco C. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int J Artif Organs. 2004;27(5):388\u201397.","journal-title":"Int J Artif Organs"},{"key":"4009_CR22","doi-asserted-by":"crossref","unstructured":"Houschyar KS, Pyles MN, Rein S, et al. Continuous hemoadsorption with a cytokine adsorber during\u00a0sepsis\u2014a review of the literature Int J Artif Organs. 2017;40(5):205\u2013211.","DOI":"10.5301\/ijao.5000591"},{"key":"4009_CR23","doi-asserted-by":"crossref","unstructured":"Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018;6(1):12.","DOI":"10.1186\/s40635-018-0177-2"},{"issue":"6","key":"4009_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/00002480-200211000-00013","volume":"48","author":"S Uchino","year":"2002","unstructured":"Uchino S, Bellomo R, Morimatsu H, et al. Cytokine dialysis: an ex vivo study. ASAIO J. 2002;48(6):650\u20133.","journal-title":"ASAIO J"},{"issue":"5","key":"4009_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00134-002-1261-2","volume":"28","author":"S Uchino","year":"2002","unstructured":"Uchino S, Bellomo R, Goldsmith D, et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med. 2002;28(5):651\u20135.","journal-title":"Intensive Care Med"},{"issue":"11","key":"4009_CR26","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/ndt\/17.11.1950","volume":"17","author":"L Cole","year":"2002","unstructured":"Cole L, Bellomo R, Davenport P, Tipping P, Uchino S, Tetta C, Rono C. The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model. Nephrol Dial Transplant. 2002;17(11):1950\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"4009_CR27","doi-asserted-by":"crossref","unstructured":"Scharf C, Schroeder I, Paal M, et al Can the cytokine adsorber\u00a0CytoSorb help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis. Ann Intensive Care. 2021 22;11(1):115","DOI":"10.1186\/s13613-021-00905-6"},{"issue":"9","key":"4009_CR28","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","volume":"27","author":"C Ronco","year":"2003","unstructured":"Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27(9):792\u2013801.","journal-title":"Artif Organs"},{"issue":"8","key":"4009_CR29","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","volume":"72","author":"JA Roberts","year":"2021","unstructured":"Roberts JA, Joynt GM, Lee A, et al. The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal replacement therapy study. Clin Infect Dis. 2021;72(8):1369\u201378.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4009_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000511","volume":"3","author":"I Martin-Loeches","year":"2021","unstructured":"Martin-Loeches I, Nunnally ME, et al. Surviving sepsis campaign: research opportunities for infection and blood purification therapies. Crit Care Explor. 2021;3(9): e0511.","journal-title":"Crit Care Explor"},{"key":"4009_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcrc.2020.09.007","volume":"63","author":"X Li","year":"2021","unstructured":"Li X, Liu C, Mao Z, Qi S, Song R, Zhou F. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: a systematic review and meta-analysis. J Crit Care. 2021;63:187\u201395.","journal-title":"J Crit Care"},{"issue":"4\u20135","key":"4009_CR32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1159\/000511725","volume":"50","author":"T Rampino","year":"2021","unstructured":"Rampino T, Gregorini M, Perotti L, et al. Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia. Blood Purif. 2021;50(4\u20135):566\u201371.","journal-title":"Blood Purif"},{"issue":"10","key":"4009_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187015","volume":"12","author":"D Sch\u00e4dler","year":"2017","unstructured":"Sch\u00e4dler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS ONE. 2017;12(10): e0187015.","journal-title":"PLoS ONE"},{"key":"4009_CR34","doi-asserted-by":"publisher","first-page":"67226","DOI":"10.3389\/fped.2021.672260","volume":"9","author":"V Sazonov","year":"2021","unstructured":"Sazonov V, Abylkassov R, Tobylbayeva Z, et al. Case Series: Efficacy and Safety of Hemoadsorption With HA-330 Adsorber in Septic Pediatric Patients With Cancer. Front Pediatr. 2021;9:67226.","journal-title":"Front Pediatr"},{"issue":"3","key":"4009_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000489921","volume":"46","author":"D Pomar\u00e8 Montin","year":"2018","unstructured":"Pomar\u00e8 Montin D, Ankawi G, et al. Biocompatibility and cytotoxic evaluation of new sorbent cartridges for blood hemoperfusion. Blood Purif. 2018;46(3):187\u201395.","journal-title":"Blood Purif"},{"issue":"12","key":"4009_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006160","volume":"96","author":"WH Li","year":"2017","unstructured":"Li WH, Yin YM, Chen H, Wang XD, Yun H, Li H, Luo J, Wang JW. Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus. Medicine (Baltimore). 2017;96(12): e6160.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"4009_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000170011","volume":"9","author":"P Morachiello","year":"1991","unstructured":"Morachiello P, Landini S, Fracasso A, Righetto F, Scanferla F, Toffoletto P, Genchi R, Bazzato G. Combined hemodialysis-hemoperfusion in the treatment of secondary hyperparathyroidism of uremic patients. Blood Purif. 1991;9(3):148\u201352.","journal-title":"Blood Purif"},{"issue":"1","key":"4009_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000067862","volume":"21","author":"JA Kellum","year":"2003","unstructured":"Kellum JA, Bellomo R, Mehta R, Ronco C. Blood purification in non-renal critical illness. Blood Purif. 2003;21(1):6\u201313.","journal-title":"Blood Purif"},{"issue":"2","key":"4009_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.5152\/tjg.2018.17415","volume":"29","author":"Z Li","year":"2018","unstructured":"Li Z, Wang G, Zhen G, Zhang Y, Liu J, Liu S. Effects of hemodialysis combined with hemoperfusion on severe acute pancreatitis. Turk J Gastroenterol. 2018;29(2):198\u2013202.","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"4009_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000490234","volume":"46","author":"G La Manna","year":"2018","unstructured":"La Manna G, Donati G. Coupled plasma filtration adsorption: a multipurpose extracorporeal detoxification therapy. Blood Purif. 2018;46(3):228\u201338.","journal-title":"Blood Purif"},{"issue":"6","key":"4009_CR41","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1159\/000513161","volume":"50","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang H, Huang Y, Wu W, Huang J, Yan D. Efficiency of double plasma molecular absorption system on the acute severe cholestatic hepatitis. Blood Purif. 2021;50(6):876\u201382.","journal-title":"Blood Purif"},{"key":"4009_CR42","first-page":"1","volume":"2","author":"SC Rodeia","year":"2021","unstructured":"Rodeia SC, Martins FL, Fortuna P, Bento L. Cytokine adsorption therapy during extracorporeal membrane oxygenation in adult patients with COVID-19. Blood Purif. 2021;2:1\u20137.","journal-title":"Blood Purif"},{"issue":"3","key":"4009_CR43","doi-asserted-by":"publisher","first-page":"388.e3","DOI":"10.1016\/j.ajem.2007.07.032","volume":"26","author":"J Jung","year":"2008","unstructured":"Jung J, Eo E, Ahn KO. A case of hemoperfusion and L-carnitine management in valproic acid overdose. Am J Emerg Med. 2008;26(3):388.e3-4.","journal-title":"Am J Emerg Med"},{"issue":"6","key":"4009_CR44","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ajem.2017.10.048","volume":"36","author":"X Yang","year":"2018","unstructured":"Yang X, Xin S, Zhang Y, Li T. Early hemoperfusion for emergency treatment of carbamazepine poisoning. Am J Emerg Med. 2018;36(6):926\u201330.","journal-title":"Am J Emerg Med"},{"key":"4009_CR45","doi-asserted-by":"crossref","unstructured":"Baylis S, Costa-Pinto R, Hodgson S, Bellomo R, Baldwin I.Combined Hemoperfusion and Continuous Veno-Venous Hemofiltration for\u00a0Carbamazepine Intoxication. Blood Purif. 2021:1\u20135. Online ahead of print.","DOI":"10.1159\/000520520"},{"issue":"10","key":"4009_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2131\/jts.45.611","volume":"45","author":"Q Xiao","year":"2020","unstructured":"Xiao Q, Wang W, Qi H, Gao X, et al. Continuous hemoperfusion relieves pulmonary fibrosis in patients with acute mild and moderate paraquat poisoning. J Toxicol Sci. 2020;45(10):611\u20137.","journal-title":"J Toxicol Sci"},{"issue":"22","key":"4009_CR47","first-page":"3521","volume":"18","author":"L Bo","year":"2014","unstructured":"Bo L. Therapeutic efficacies of different hemoperfusion frequencies in patients with organophosphate poisoning. Eur Rev Med Pharmacol Sci. 2014;18(22):3521\u20133.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4009_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.toxicon.2021.04.011","volume":"197","author":"Y Li","year":"2021","unstructured":"Li Y, Qiu Z, Huang L, Cao C. Extracorporeal membrane oxygenation combined with sequential blood purification in the treatment of myocardial damage and cardiac arrest caused by mushroom poisoning. Toxicon. 2021;197:65\u20139.","journal-title":"Toxicon"},{"issue":"4","key":"4009_CR49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12072-016-9775-9","volume":"11","author":"W Kittanamongkolchai","year":"2017","unstructured":"Kittanamongkolchai W, El-Zoghby ZM, Eileen Hay J, et al. Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease. Hepatol Int. 2017;11(4):384\u20139.","journal-title":"Hepatol Int"},{"key":"4009_CR50","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000102130","volume":"156","author":"A Santoro","year":"2007","unstructured":"Santoro A, Mancini E, Ferramosca E. Faenza S Liver support systems. Contrib Nephrol. 2007;156:396\u2013404.","journal-title":"Contrib Nephrol"},{"key":"4009_CR51","doi-asserted-by":"crossref","unstructured":"Magnani S, Atti M. Uremic toxins and blood purification: a review of current evidence and future perspectives. Toxins (Basel). 2021;13(4):246.","DOI":"10.3390\/toxins13040246"},{"key":"4009_CR52","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/cc5780","volume":"11","author":"DN Cruz","year":"2007","unstructured":"Cruz DN, Perazella MA, Bellomo R, et al. Effectivness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11:R47.","journal-title":"Crit Care"},{"key":"4009_CR53","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock. JAMA. 2009;301:2445\u201352.","journal-title":"JAMA"},{"key":"4009_CR54","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"D Payen","year":"2015","unstructured":"Payen D, Guilbert J, Launey Y, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicentre randomized control trial. Intensive Care Med. 2015;41:975\u201384.","journal-title":"Intensive Care Med"},{"issue":"14","key":"4009_CR55","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level. JAMA. 2018;320(14):1455\u201363.","journal-title":"JAMA"},{"issue":"12","key":"4009_CR56","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H. Antonelli M Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44(12):2205\u201312.","journal-title":"Intensive Care Med"},{"issue":"11","key":"4009_CR57","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/aor.14024","volume":"45","author":"AA Nassiri","year":"2021","unstructured":"Nassiri AA, Hakemi MS, Miri MM, Shahrami R, Koomleh AA, Sabaghian T. Blood purification with CytoSorb in critically ill COVID-19 patients: a case series of 26 patients. Artif Organs. 2021;45(11):1338\u201347.","journal-title":"Artif Organs"},{"key":"4009_CR58","doi-asserted-by":"crossref","unstructured":"Boss K, Jahn M, Wendt D, Haidari Z, et al. Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery. PLoS ONE. 2021 8;16(2):e0246299.","DOI":"10.1371\/journal.pone.0246299"},{"issue":"1","key":"4009_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5492\/wjccm.v10.i1.22","volume":"10","author":"R Paul","year":"2021","unstructured":"Paul R, Sathe P, Kumar S, Prasad S, Aleem M, Sakhalvalkar P. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb) in patients with sepsis and septic shock. World J Crit Care Med. 2021;10(1):22\u201334.","journal-title":"World J Crit Care Med"},{"issue":"5","key":"4009_CR60","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1111\/aor.13864","volume":"45","author":"A Alharthy","year":"2021","unstructured":"Alharthy A, Faqihi F, Memish ZA. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: a case-series. Artif Organs. 2021;45(5):E101\u201312.","journal-title":"Artif Organs"},{"issue":"1","key":"4009_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13054-019-2588-1","volume":"23","author":"WP Brouwer","year":"2019","unstructured":"Brouwer WP, Duran S, Kuijper M. Ince C Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317.","journal-title":"Crit Care"},{"key":"4009_CR62","doi-asserted-by":"crossref","unstructured":"Sch\u00e4dler D, Pausch C, Heise D, et al The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS One. 2017;12(10):e0187015.","DOI":"10.1371\/journal.pone.0187015"},{"issue":"7","key":"4009_CR63","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","volume":"9","author":"A Supady","year":"2021","unstructured":"Supady A, Weber E, Rieder M, et al. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021;9(7):755\u201362.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"4009_CR64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000509107","volume":"50","author":"A Esmaeili Vardanjani","year":"2021","unstructured":"Esmaeili Vardanjani A, Ronco C, et al. Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19. Blood Purif. 2021;50(2):257\u201360.","journal-title":"Blood Purif"},{"key":"4009_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.672260","volume":"9","author":"V Sazonov","year":"2021","unstructured":"Sazonov V, Abylkassov R, Tobylbayeva Z, Saparov A, Mironova O, Poddighe D. Case series: efficacy and safety of hemoadsorption with HA-330 adsorber in septic pediatric patients with cancer. Front Pediatr. 2021;9: 672260.","journal-title":"Front Pediatr"},{"key":"4009_CR66","doi-asserted-by":"crossref","unstructured":"Huang Z, Wang S, Su W, Liu J-Y. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2010;14:596\u2013602.","DOI":"10.1111\/j.1744-9987.2010.00825.x"},{"key":"4009_CR67","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1744-9987.2012.01083.x","volume":"17","author":"Z Huang","year":"2013","unstructured":"Huang Z, Wand S, Yang Z, Liu J. Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2013;17:454\u201361.","journal-title":"Ther Apher Dial"},{"key":"4009_CR68","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019058","volume":"99","author":"L Chu","year":"2020","unstructured":"Chu L, Li G, Yu Y, et al. Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock. Medicine. 2020;99: e19058.","journal-title":"Medicine"},{"key":"4009_CR69","doi-asserted-by":"crossref","unstructured":"Rifkin BS, Stewart IJ. Seraph-100 hemoperfusion in SARS-CoV-2-infected patients early in critical illness: a case series. Blood Purif 2021, July 14 Online ahead of print.","DOI":"10.1159\/000517430"},{"key":"4009_CR70","volume":"2","author":"SW Olson","year":"2020","unstructured":"Olson SW, Oliver JD, Collen J, et al. Treatment for severe coronavirus disease 2019 with the Seraph-100 microbind affinity blood filter. Crit Care Expl. 2020;2: e0180.","journal-title":"Crit Care Expl"},{"key":"4009_CR71","doi-asserted-by":"crossref","unstructured":"Schmidt JJ, Borchina DN, van\u2019t Klooster M, et al. Interim analysis of the COSA (COVID-19 patients treated with the Seraph 100 Microbind Affinity filter) registry. Nepjhol Dial Transplant. 2021, Dec 7, Online ahead of print.","DOI":"10.21203\/rs.3.rs-557453\/v1"},{"key":"4009_CR72","doi-asserted-by":"crossref","unstructured":"Diab M, Lehmann T, Bothe W, et al. Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a muylticenter, randomized, controlled trial. Circulation. 2022, Feb 25 Online ahead of print.","DOI":"10.1161\/CIRCULATIONAHA.122.061219"},{"key":"4009_CR73","doi-asserted-by":"crossref","unstructured":"Stockmannn H, Thelen P, Stroben F, et al. Cytosorb rescue for COVID-19 patients with vasoplegic shock and multiple organ failure: a prospective, open label, randomized controlled pilot study. Crit Care Med. 2022; Feb 9 [Online ahead of print].","DOI":"10.1097\/CCM.0000000000005493"},{"issue":"1\u20133","key":"4009_CR74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000493523","volume":"47","author":"G Ankawi","year":"2019","unstructured":"Ankawi G, Fan W, Pomar\u00e8 Montin D, Lorenzin A, Neri M, Caprara C, de Cal M, Ronco C. A new series of sorbent devices for multiple clinical purposes: current evidence and future directions. Blood Purif. 2019;47(1\u20133):94\u2013100.","journal-title":"Blood Purif"},{"issue":"23","key":"4009_CR75","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.3390\/ijms222312786","volume":"22","author":"T K\u00f6hler","year":"2021","unstructured":"K\u00f6hler T, Schwier E, Praxenthaler J, Kirchner C, Henzler D, Eickmeyer C. Therapeutic modulation of the host defense by hemoadsorption with CytoSorb\u00ae-Basics, indications and perspectives\u2014a scoping review. Int J Mol Sci. 2021;22(23):12786.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4009_CR76","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1159\/000505146","volume":"49","author":"S De Rosa","year":"2020","unstructured":"De Rosa S, Samoni S, Ronco C. Sequential extracorporeal therapy collaborative device and timely support for endotoxic, septic, and cardiac shock: a case Report. Blood Purif. 2020;49(4):502\u20138.","journal-title":"Blood Purif"},{"issue":"4","key":"4009_CR77","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0391398818823762","volume":"42","author":"D Tomescu","year":"2019","unstructured":"Tomescu D, Popescu M, David C, Dima S. Clinical effects of hemoadsorption with CytoSorb\u00ae in patients with severe acute pancreatitis: a case series. Int J Artif Organs. 2019;42(4):190\u20133.","journal-title":"Int J Artif Organs"},{"issue":"5","key":"4009_CR78","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/aor.13606","volume":"44","author":"G Klinkmann","year":"2020","unstructured":"Klinkmann G, Stope MB, Meyer A. Cytokine adsorption as a promising option for septic shock and multiple organ failure due to Candida infection and decompensated type 1 diabetes mellitus. Artif Organs. 2020;44(5):522\u20135.","journal-title":"Artif Organs"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04009-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04009-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04009-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T08:10:28Z","timestamp":1668327028000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04009-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4009"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04009-w","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof Claudio Ronco, in the last three years, has been consultant, medical advisor or part of the speaker bureau receiving fees from the following companies:\nAsahi Medical, Aferetica, Baxter, B.Braun, Biomerieux,  Bioporto, Cytosorbents, ESTOR, Fresenius Medical Care, GE Healthcare,  Jafron, Kaneka, Medica, Medtronic- Bellco, Nipro,  Spectral, Toray\nProf Rinaldo Bellomo, in the last three years, has been consultant, medical advisor or part of the speaker bureau receiving fees from the following companies: Baxter, BBraun, Jafron, Spectral, Bard, Endpoint, Notus, AM Pharma, Nutromics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}